BOUT vs. XPH ETF Comparison
Comparison of Innovator IBD Breakout Opportunities ETF (BOUT) to SPDR S&P Pharmaceuticals ETF (XPH)
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.
Grade (RS Rating)
Last Trade
$37.01
Average Daily Volume
1,998
44
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.Grade (RS Rating)
Last Trade
$46.16
Average Daily Volume
40,383
44
Performance
| Period | BOUT | XPH |
|---|---|---|
| 30 Days | 2.00% | 4.18% |
| 60 Days | 1.00% | 3.86% |
| 90 Days | 7.18% | 9.06% |
| 12 Months | 27.28% | 28.77% |
BOUT Overweight 42 Positions Relative to XPH
| Symbol | Grade | Weight | |
|---|---|---|---|
| PACS | A | 4.48% | |
| MS | B | 4.47% | |
| LBRDK | A | 4.44% | |
| NEM | D | 4.42% | |
| VIK | A | 4.39% | |
| EXPE | B | 4.28% | |
| EQIX | B | 4.25% | |
| AHR | A | 4.24% | |
| IDCC | A | 4.01% | |
| ETN | B | 3.82% | |
| SPGI | D | 3.81% | |
| EQH | B | 3.78% | |
| CRM | A | 3.73% | |
| BAH | A | 3.73% | |
| DVA | D | 3.71% | |
| PGR | D | 3.63% | |
| CRDO | A | 2.87% | |
| VRNS | D | 2.61% | |
| ULS | B | 2.59% | |
| IR | C | 2.49% | |
| DT | B | 2.49% | |
| NMIH | D | 2.44% | |
| ONON | D | 2.35% | |
| TSM | B | 1.31% | |
| TBBK | D | 1.28% | |
| NOW | A | 1.27% | |
| CDNA | D | 1.24% | |
| SCCO | B | 1.22% | |
| SN | C | 1.2% | |
| TCOM | A | 1.14% | |
| BEKE | A | 1.06% | |
| ROAD | B | 0.45% | |
| AXON | B | 0.43% | |
| TPH | D | 0.42% | |
| IBKR | A | 0.42% | |
| CWAN | B | 0.42% | |
| AVGO | B | 0.42% | |
| ALKT | B | 0.42% | |
| GMED | A | 0.41% | |
| ACGL | F | 0.4% | |
| PLMR | D | 0.39% | |
| JD | A | 0.38% |
BOUT Underweight 42 Positions Relative to XPH
| Symbol | Grade | Weight | |
|---|---|---|---|
| LBPH | A | -4.15% | |
| BMY | A | -3.75% | |
| EWTX | B | -3.64% | |
| ITCI | A | -3.49% | |
| CTLT | D | -3.47% | |
| JAZZ | D | -3.46% | |
| JNJ | D | -3.44% | |
| RPRX | D | -3.43% | |
| VTRS | B | -3.43% | |
| PFE | D | -3.41% | |
| LLY | F | -3.36% | |
| ZTS | D | -3.31% | |
| AXSM | C | -3.3% | |
| MRK | F | -3.18% | |
| PRGO | D | -3.15% | |
| ELAN | D | -2.98% | |
| OGN | D | -2.93% | |
| ARVN | C | -2.76% | |
| SAVA | D | -2.7% | |
| TARS | A | -2.36% | |
| AMPH | A | -2.25% | |
| PBH | A | -2.22% | |
| SUPN | B | -2.03% | |
| PCRX | C | -2.01% | |
| LGND | A | -1.72% | |
| OCUL | B | -1.59% | |
| ANIP | F | -1.57% | |
| HROW | C | -1.46% | |
| HRMY | D | -1.27% | |
| AMRX | B | -1.24% | |
| WVE | B | -1.16% | |
| INVA | C | -1.02% | |
| LQDA | C | -0.99% | |
| PLRX | A | -0.93% | |
| MNMD | C | -0.9% | |
| EYPT | C | -0.87% | |
| PHAT | B | -0.87% | |
| FULC | F | -0.83% | |
| ELVN | B | -0.75% | |
| EOLS | A | -0.7% | |
| NUVB | F | -0.49% | |
| XERS | A | -0.49% |
BOUT: Top Represented Industries & Keywords
XPH: Top Represented Industries & Keywords
Compare ETFs
